Source guides · 21
- Neurodegenerative and psychiatric overlap in frontotemporal lobar degeneration: a case of familial frontotemporal dementia presenting with catatonia. · Full Atlas view
- Neurodegenerative and psychiatric overlap in frontotemporal lobar degeneration: a case of familial frontotemporal dementia presenting with catatonia. · Full Atlas view
- Neurodevelopmental Disorders, Schizophrenia Spectrum Disorders and Catatonia: The "Iron Triangle" Rediscovered in a Case Report. · Full Atlas view
- Neuroleptic Malignant Syndrome Induced by Multiple Antipsychotics in a Patient Receiving Methadone. · Full Atlas view
- Neuroleptic Malignant Syndrome or Catatonia? A Case Report. · Full Atlas view
- Neuroleptic Malignant Syndrome/Malignant Catatonia in Child Psychiatry: Literature Review and a Case Series. · Full Atlas view
- Neuroleptic Malignant Syndrome/Malignant Catatonia in Child Psychiatry: Literature Review and a Case Series. · Full Atlas view
- Neuroleptic malignant syndrome and clozapine withdrawal-induced catatonia: a case report. · Full Atlas view
- Neuroleptic malignant syndrome and delirious mania as malignant catatonia in autism: prompt relief with electroconvulsive therapy. · Full Atlas view
- Neuroleptic malignant syndrome and delirious mania as malignant catatonia in autism: prompt relief with electroconvulsive therapy. · Full Atlas view
- Neuroleptic malignant syndrome and neuroleptic-induced catatonia: differential diagnosis and treatment. · Full Atlas view
- Neuroleptic malignant syndrome and serotonin syndrome. · Full Atlas view
- Neuroleptic malignant syndrome associated with atypical antipsychotics: A case report. · Full Atlas view
- Neuroleptic malignant syndrome in an adolescent after brief exposure to olanzapine. · Full Atlas view
- Neuroleptic malignant syndrome induced by atypical neuroleptics and responsive to lorazepam. · Full Atlas view
- Neuroleptic malignant syndrome with prolonged catatonia in a dopa-responsive dystonia patient. · Full Atlas view
- Neuroleptic malignant syndrome with prolonged catatonia in a dopa-responsive dystonia patient. · Full Atlas view
- Neuroleptic malignant syndrome. · Full Atlas view
- Neuroleptic malignant syndrome: Possible induction by olanzapine in a case with relapsing catatonia. · Full Atlas view
- Neuroleptic malignant syndrome: a review and report of six cases. · Full Atlas view
- Neuroleptic malignant syndrome: further lessons from a case report. · Full Atlas view
- Neuroleptic malignant syndrome: risk factors, pathophysiology, and treatment. · Full Atlas view
- Neuroleptic-induced catatonia after abrupt withdrawal of amantadine during neuroleptic therapy. · Full Atlas view
- Neuroleptic-induced catatonia or a mild form of neuroleptic malignant syndrome? · Full Atlas view
- Neuroleptic-related catatonia in systemic lupus · Full Atlas view
- Neurological Deficits After Lithium Intoxication in a Bipolar Woman With Catatonia Treated With ECT. · Full Atlas view
- Neurological Deficits After Lithium Intoxication in a Bipolar Woman With Catatonia Treated With ECT. · Full Atlas view
- Neuromodulation to Facilitate the Effect of Ketamine · Full Atlas view
- Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder · Full Atlas view
- Neuropharmacological interaction between ketamine, and physostigmine, diazepam or propranolol. · Full Atlas view
- Neurophysiological Resting-State Markers of Catatonia in Schizophrenia and Mood Disorders. · Full Atlas view
- Neurophysiological Resting-State Markers of Catatonia in Schizophrenia and Mood Disorders. · Full Atlas view
- Neuroprotective effect of Tinospora cordifolia ethanol extract on 6-hydroxy dopamine induced Parkinsonism. · Full Atlas view
- Neuropsychiatric Systemic Lupus Erythematosus Presenting With Striatal Lupus Encephalitis and Catatonia: A Multidisciplinary Diagnostic Challenge. · Full Atlas view
- Neuropsychiatric Systemic Lupus Erythematosus Presenting With Striatal Lupus Encephalitis and Catatonia: A Multidisciplinary Diagnostic Challenge. · Full Atlas view
- Neuropsychiatric Systemic Lupus Erythematosus Presenting With Striatal Lupus Encephalitis and Catatonia: A Multidisciplinary Diagnostic Challenge. · Full Atlas view
- New catatonic signs after a first session in schizoaffective illness · Full Atlas view
- Nicotinic Modulation of Schizophrenia-like Information Processing Deficits in Healthy Subjects · Full Atlas view
- Nine-year follow-up · Full Atlas view
- Nitecapone and selegiline as effective adjuncts to L-DOPA in reserpine-induced catatonia in mice. · Full Atlas view
- Non-Catatonic Mutism as a Presentation of Psychosis: A Case Study. · Full Atlas view
- Non-Catatonic Mutism as a Presentation of Psychosis: A Case Study. · Full Atlas view
- Non-N-methyl-D-aspartate Autoimmune Encephalopathy and Catatonia Treated With Electroconvulsive Therapy: A Pediatric Case Series and Treatment Guidelines. · Full Atlas view
- Non-N-methyl-D-aspartate Autoimmune Encephalopathy and Catatonia Treated With Electroconvulsive Therapy: A Pediatric Case Series and Treatment Guidelines. · Full Atlas view
- Non-Psychosis Symptoms of Clozapine Withdrawal: a Systematic Review. · Full Atlas view
- Non-invasive brain stimulation for treating catatonia · Full Atlas view
- Non-invasive brain stimulation for treating catatonia: a systematic review. · Full Atlas view
- Non-invasive brain stimulation for treating catatonia: a systematic review. · Full Atlas view
- Nonconvulsive status epilepticus presenting with catatonia · Full Atlas view
- Novel Antineuronal Autoantibodies With Somatodendritic Staining Pattern in a Patient With Autoimmune Psychosis. · Full Atlas view
- OTHR-07. LIFE THREATENING CATATONIA AND THE USE OF ELECTROCONVULSIVE THERAPY IN A PATIENT WITH RELAPSED MEDULLOBLASTOMA · Full Atlas view
- OTHR-07. LIFE THREATENING CATATONIA AND THE USE OF ELECTROCONVULSIVE THERAPY IN A PATIENT WITH RELAPSED MEDULLOBLASTOMA · Full Atlas view
- Observation of Safety and Tolerability Within 1 Year of the Use of R-ketamine / Placebo in Drug-resistant Depression · Full Atlas view
- Observational study in a Canadian First Nations community · Full Atlas view
- Observe movement before speaking · Full Atlas view
- Official instructions for downloading records · Full Atlas view
- Olazabal Eizaguirre and colleagues, 2016 · Full Atlas view
- Oldham on definitions of catatonic signs · Full Atlas view
- Oldham’s clinical work · Full Atlas view
- One-year outcome after response to ECT · Full Atlas view
- Onset of catatonia at puberty: electroconvulsive therapy response in two autistic adolescents. · Full Atlas view
- Onset of catatonia at puberty: electroconvulsive therapy response in two autistic adolescents. · Full Atlas view
- Open Label Ketamine Treatment for Major Depressive Disorder in Veterans · Full Atlas view
- Open Label Multi-Site Study of Safety and Effects of MDMA-assisted Therapy for Treatment of PTSD · Full Atlas view
- Open Label Study of MDMA-assisted Psychotherapy for Treatment of PTSD With Optional fMRI Sub-Study · Full Atlas view
- Open Study of the Neurobiological Effects of Intranasal Ketamine in Children and Adults With Bipolar Disorder · Full Atlas view
- Open-label bipolar II study · Full Atlas view
- Optimization of IV Ketamine for Treatment Resistant Depression · Full Atlas view
- Optimizing ECT Technique in Treating Catatonia. · Full Atlas view
- Optimizing ECT Technique in Treating Catatonia. · Full Atlas view
- Oral Aspirin + Ketamine as Adjunct to Oral Antidepressant Therapy for Depression · Full Atlas view
- Oral Ketamine in the Treatment of Depression and Anxiety in Patients With Cancer · Full Atlas view
- Oral and Sublingual Ketamine · Full Atlas view
- Oral and intranasal ketamine in resistant catatonia · Full Atlas view
- Organic catatonia following frontal lobe injury: response to clozapine. · Full Atlas view
- Original podcast and resources · Full Atlas view
- Orsini and colleagues, 2026 · Full Atlas view
- Other features of the clinical examination · Full Atlas view
- Ovarian teratoma-associated encephalitis · Full Atlas view
- Overcoming Obstacles to Clozapine Treatment: A Case of Clozapine Rechallenge in ECT-Resistant Schizophrenia With Catatonic Features. · Full Atlas view
- Overcoming Obstacles to Clozapine Treatment: A Case of Clozapine Rechallenge in ECT-Resistant Schizophrenia With Catatonic Features. · Full Atlas view
- Overlap without equivalence: Delirium and catatonia in critical illness. · Full Atlas view
- Overlap without equivalence: Delirium and catatonia in critical illness. · Full Atlas view
- Overlapping but distinct: delirium and catatonia-related features in critically ill patients. · Full Atlas view
- Overlapping but distinct: delirium and catatonia-related features in critically ill patients. · Full Atlas view
- Owner’s 24-hour zolpidem model · Full Atlas view
- Owner’s 28-day bridge model · Full Atlas view
- Owner’s lorazepam depletion and reinstatement model · Full Atlas view
- Owner’s motor–speech circuit and modality matcher · Full Atlas view
- PCORI Comparative Effectiveness Study-Esketamine (Spravato) vs. Ketamine-Equivalence Study · Full Atlas view
- PERSISTENT CATATONIA IN A PREGNANT NIGERIAN WOMAN: A CASE REPORT. · Full Atlas view
- PERSISTENT CATATONIA IN A PREGNANT NIGERIAN WOMAN: A CASE REPORT. · Full Atlas view
- PET Imaging of mGLuR5 With Drug Challenge · Full Atlas view
- PTSD with secondary psychotic features · Full Atlas view
- Pain and disability in an open-label PTSD trial · Full Atlas view
- Palliative ECT for Catatonia in a Terminal Cancer Patient: A Case Report. · Full Atlas view
- Palliative ECT for Catatonia in a Terminal Cancer Patient: A Case Report. · Full Atlas view
- Palliative psychiatry for a patient with treatment-refractory schizophrenia and severe chronic malignant catatonia: case report. · Full Atlas view
- Palliative psychiatry for a patient with treatment-refractory schizophrenia and severe chronic malignant catatonia: case report. · Full Atlas view
- Paper proposing the fear-response hypothesis · Full Atlas view